Based on large-number clinical data analysis, our study systematically investigated the individual and synergistic effects of polymorphisms of TS, MTHFR, MTR and MTR on the prognosis of stage II-III GC patients accepted 5-FU-based adjuvant chemotherapy. The gene discussed is MTHFR; the disease is gastric cancer.